pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 21·1 min read
save

Trump administration defers over $1 billion in Medicaid payments to California and Minnesota over fraud concerns

Jul 21, 2026·read at STAT ↗RegulatoryNegative

The Trump administration announced it is holding back more than $1 billion in Medicaid funds for California and Minnesota, saying the states have suspected fraud and non‑compliance.

Health Secretary Robert F. Kennedy Jr. said the step is part of a strategy to stop fraud before it happens, rather than recover money after prosecutions, and tied it to a broader anti‑fraud campaign launched earlier this year.

The deferral follows earlier similar actions in the two states and is framed as a taxpayer‑saving measure amid rising health‑care costs and the upcoming November midterm elections.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Trump administration says it’s deferring $1B in Medicaid payments to California and Minnesota”

read at STAT ↗
1,002 words · retrieved Jul 21
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING2Ultragenyx Pharmaceutical Inc.
drugs
Rare Disease
topics
PainRare Disease

related stories

  • 2d agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • 5d agoAs MAHA champions nutrition, it’s ignoring the experts, dietitians saySTAT
  • Aug 21Werewolf and Ambros to tie the knot in $150M rare disease dealBioSpace
  • Aug 21STAT+: Up and down the ladder: The latest comings and goingsSTAT
  • Aug 21Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drugFierce Biotech